Amedisys Inc. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,249
1,205
1,281
1,437
1,534
1,663
Cost of Goods Sold (COGS) incl. D&A
755
718
746
853
918
1,006
Gross Income
494
486
535
585
616
656
SG&A Expense
487
449
466
523
504
499
Unusual Expense
163
13
77
4
34
1
Non Operating Income/Expense
4
2
10
4
4
2
Interest Expense
4
8
11
5
5
7
Pretax Income
153
21
-
62
81
159
Income Tax
59
8
2
24
50
39
Consolidated Net Income
95
13
2
38
31
120
Net Income
93
13
3
37
30
119
Net Income After Extraordinaries
90
13
3
37
30
119
Net Income Available to Common
96
13
3
37
30
119
EPS (Basic)
3.08
0.39
0.09
1.10
0.88
3.55
Basic Shares Outstanding
31
32
33
33
34
33
EPS (Diluted)
3.08
0.39
0.09
1.10
0.88
3.55
Diluted Shares Outstanding
31
33
33
34
34
34
EBITDA
45
65
88
81
129
171
Non-Operating Interest Income
-
-
-
-
-
-
Minority Interest Expense
-
-
1
2
1
1
Equity in Affiliates (Pretax)
2
3
10
6
3
8
About Amedisys
View Profile
